Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

Authors' contribution

YN participated in the interpretation of the study and in the preparation of this letter.

Funding

This reanalysis was supported by JSPS KAKENHI Grant Number 22K12890.

Conflicts of interest

YN declares that there is no competing interest.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Code availability

Not applicable.

留言 (0)

沒有登入
gif